nach oben

Rheumatology International

Erschienen in:

01.01.2012 | Case Report

Etanercept and anakinra can prolong febrile episodes in patients with hyperimmunoglobulin D and periodic fever syndrome

verfasst von: Hiba M. Shendi, Deirdre Walsh, J. David M. Edgar

Erschienen in: Rheumatology International | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

Hyperimmunoglobulin D and periodic fever syndrome (HIDS) is a rare, hereditary autoinflammatory condition, characterized by recurrent inflammatory episodes. There is no proven treatment for HIDS, but various drugs including, non-steroidal anti-inflammatory drugs, colchicine, steroids, statins and thalidomide have all been tried. Recently, some patients have demonstrated a good clinical response to either etanercept or anakinra. We report a case of a 10-year-old girl who experienced prolonged and severe inflammatory attacks, when she was treated with etanercept, and later with anakinra.

Drenth JPH, Cuisset L, Grateau G, Vasseur C, van de Velde-Visser SD, de Jong JG, Beckmann JS, van der Meer JWM, Delpech M (1999) Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. Nat Genet 22:178–181PubMedCrossRef

Dreneth JPH, Haagsma CJ, van der Meer JW (1994) Hyperimmunoglobulinaemia D and periodic fever syndrome. The clinical spectrum in a series of 50 patients. International hyper-IgD study group. Medicine (Baltimore) 73:133–144

van der Hilst JC, Bodar EJ, Barron KS, Fenkel J, Drenth JPH, van der Meer JWM, Simon A et al (2008) Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulin D syndrome. Medicine (Baltimore) 87:301–310CrossRef

Lachmann HJ, Goodman HJ, Andrews PA, Gallagher H, Marsh J, Breuer S, Rowczenio DM, Bybee A, Hawkins PN (2006) AA amyloidosis complicating hyperimmunoglobulinaemia D with periodic fever syndrome: a report of two cases. Arthritis Rheum 54:2010–2014PubMedCrossRef

Prietsch V, Mayatepek E, Krastel H, Haas D, Zundel D, Waterham HR, Wanders RJ, Gibson KM, Hoffman GF (2003) Mevalonate kinase deficiency: enlarging the clinical and biochemical spectrum. Paediatrics 111:258–261CrossRef

de Dios Garcia-Diaz J, Alvarez-Blanco MJ (2001) Glucocorticoids but not NSAID abort attacks in hyper-IgD, periodic fever syndrome. J Rheumatol 28:925–926PubMed

Ostuni PA, Lazzarin P, Ongaro G, Gusi R, Todesco S, Gambari PF (1988) Hyper IGD syndrome: a new case treated with colchicine. Clin Rheumatol 7:398–401PubMedCrossRef

Simon A, Drewe E, van der Meer JW, Powell RJ, Kelley RI, Stalenhoef AF, Drenth JP (2004) Simvastatin treatment for inflammatory attacks of hyperimmunoglobulinaemia D and periodic fever syndrome. Clin Pharmacol Ther 75:476–483PubMedCrossRef

Topaloglu R, Ayaz NA, Waterham HR, Yüce A, Gumruk F, Sandal Ö (2008) Hyperimmunoglobulinaemia D and periodic fever syndrome: treatment with etanercept and follow-up. Clin Rheumatol 27:1317–1320PubMedCrossRef

10.

Drenth JP, Vonk AG, Simon A, Powell R, van der Meer JW (2001) Limited efficacy of thalidomide in the treatment of febrile attacks of the hyper-IgD and periodic fever syndrome: a randomized, double-blind, placebo-controlled trial. J Pharmacol Exp Ther 298:1221–1226PubMed

11.

Takada K, Aksentijevich I, Mahadevan V, Dean JA, Kelley RI, Kastner DL (2003) Favorable preliminary experience with etanercept in two patients with the hyperimmunoglobulinaemia D and periodic fever syndrome. Arthritis Rheum 48:2645–2651PubMedCrossRef

12.

Demirkaya E, Caglar MK, Waterham HR, Topaloglu R, Ozen S (2006) A patient with hyper IgD syndrome responding to anti-TNF treatment. Clin Rheumatol 26:1757–1759PubMedCrossRef

13.

Cailliez M, Garaix F, Rousset-Rouviere C, Bruno D, Kone-Paut I, Sarles J, Chabrol B, Tsimaratos M (2006) Anakinra is safe and effective in controlling hyperimmunoglobulinaemia D syndrome-associated febrile crisis. J Inherit Metab Dis 29:763PubMedCrossRef

14.

Bodar EJ, van der Hilst JCH, Drenth JPH, van der Meer JWM, Simon A (2005) Effect of etanercept and anakinra on inflammatory attacks in the hyper-IgD syndrome: introducing a vaccine provocation model. Neth J Med 63:260–264PubMed

15.

Rigante D, Ansuini V, Bertoni B, Pugliese AL, Avallone L, Federico G, Stabile A (2006) Treatment with anakinra in hyperimmunoglobulinaemiaD/periodic fever syndrome. Rheumatol Int 27:97–100PubMedCrossRef

16.

Drenth JP, van Deuren M, van der Ven-Jongerkrijg J, Schalkwijk CG, van der Meer JW (1995) Cytokine activation during attacks of hyperimmunoglobulinemia D and periodic fever syndrome. Blood 85:3586–3593PubMed

17.

Marchetti F, Barbi E, Tommasini A, Oretti C, Ventura A (2004) Inefficacy of etanercept in a chid with hyper-IgD syndrome and periodic fever. Clin Exp Rheumatol 22:791–792PubMed

18.

Nevyjel M, Pontillo A, Calligaris L, Tommasini A, D’Osualdo A, Waterham HR, Granzotto M, Crovella S, Barbi E, Ventura A (2007) Diagnostics and therapeutic insights in a severe case of mevalonate kinase deficiency. Paediatrics 119:e523–e557CrossRef

19.

Lequerre T, Vittecoq O, Pouplin S, Klemmer N, Mejjad O, Daragon A, Prieur AM, Le Loet X (2007) Mevalonate kinase deficiency with structural damage responsive to anakinra. Rheumatology 46:1860–1862PubMedCrossRef

Titel: Etanercept and anakinra can prolong febrile episodes in patients with hyperimmunoglobulin D and periodic fever syndrome
verfasst von: Hiba M. Shendi
Deirdre Walsh
J. David M. Edgar
Publikationsdatum: 01.01.2012
Verlag: Springer-Verlag
Erschienen in: Rheumatology International / Ausgabe 1/2012
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI: https://doi.org/10.1007/s00296-009-1322-8

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

24.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Etanercept and anakinra can prolong febrile episodes in patients with hyperimmunoglobulin D and periodic fever syndrome

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2012

Early endoscopy in systemic sclerosis without gastrointestinal symptoms

An unusual case of undifferentiated connective tissue disease presenting as cardiac tamponade

Thrombocytosis in rheumatoid arthritis: JAK2V617F-positive essential thrombocythemia

High incidence of intolerance to tuberculosis chemoprophylaxis

TRAF2 and cIAP2 involve in TWEAK-induced MMP-9 production in fibroblast-like synoviocytes

Alfacalcidol improves muscle power, muscle function and balance in elderly patients with reduced bone mass

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Update Innere Medizin